Company Monitoring Page for Agenus

latest headlines for company on cafepharma

Agenus commences Phase 2 study of HerpV vaccine for treatment of genital herpes
Yahoo/Fly the on Wall
Tue, 10/23/12 - 09:10 am
Tags:
HerpV, vaccines, genital herpes, Agenus
Agenus' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Sat, 08/4/12 - 11:27 am
Tags:
Agenus, earnings
Small-Cap Adjuvants For Cancer Treatment
Seeking Alpha
Sat, 07/28/12 - 11:32 am
Tags:
Agenus, QS-21, OncoSec Medical, OMS ElectroImmunotherapy, Oncothyreon, ONO-4641, Stimuvax
Agenus: Buy Or Ready To Bust?
Seeking Alpha
Tue, 04/3/12 - 09:01 am
Tags:
Agenus, glioma, Prophage
7 Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Sat, 03/17/12 - 10:46 am
Tags:
Agenus, China Biologic, Halozyme, Incyte, NuPathe, QLT, Seattle Genetics
Agenus Continues to Outperform
Seeking Alpha
Sat, 03/17/12 - 10:42 am
Tags:
Agenus, vaccines, cancer vaccines
Agenus Still Gaining On GSK Agreement Expansion
Seeking Alpha
Thu, 03/15/12 - 09:49 am
Tags:
Agenus, GSK, QS-21
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Mon, 03/5/12 - 11:13 am
Tags:
Dendreon, Provenge, prostate cancer, Celldex, Agenus, Cel-Sci, ImmunoCellular
How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch
Minyanville
Fri, 02/24/12 - 10:02 am
Tags:
earnings, Dendreon, Agenus, Galena Biopharma, ImmunoCellular
Agenus Announces Reverse Stock Split
Yahoo/GlobeNewswire
Sat, 10/1/11 - 12:39 pm
Tags:
Agenus
Biotech Data Mining Comes Up Empty
TheStreet.com
Wed, 06/29/11 - 10:26 am
Tags:
data mining, Cel-Sci, Apricus Biosciences, Osiris, Transdel, Agenus, Introgen, Cell Therapeutics
ASCO: Cancer Stock Winners, Losers
TheStreet.com
Thu, 05/19/11 - 01:56 pm
Tags:
ASCO, Vical, Oxigene, Agenus, Ariad Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.